
Gaush Meditech Ltd
2407.HKHKSEHealthcareMedical - Devices
Latest quote
HK$4.69
+HK$0.29 · +6.59%
2407.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteGaush Meditech Ltd., alongside its affiliates, is engaged in the global research, development, manufacturing, and sale of specialized medical devices for ophthalmology, serving markets both within the People's Republic of China and internationally. The company's operations are divided into four main divisions: Proprietary Products, Distribution, Technical Services, and Other Business Ventures. Its advanced ophthalmic instruments are crucial for the diagnosis, treatment, and surgical intervention of a broad spectrum of eye conditions, including vitreoretinal disorders, cataracts, glaucoma, refractive errors, ocular surface diseases, and issues in optometry and pediatric ophthalmology. The Proprietary Products division focuses on creating and producing its own line of surgical apparatus, accompanying software, intraocular lenses, and equipment for diagnosing and treating eye ailments, along with their associated consumables. Conversely, the Distribution division is responsible for selling diagnostic devices, equipment for ocular fundus examination, surgical and treatment instruments, and related consumables. The Technical Services segment provides essential support, covering warranty services, maintenance, and the supply of post-sales consumables. Lastly, the Other Business Ventures division handles equipment rental, agent registration services, and the licensing of intellectual property. Gaush Meditech Ltd. reaches its clientele—comprising public and private hospitals, among other customers—through both direct sales and a network of distributors. The company was established in 1998 and has its corporate headquarters situated in Beijing, China.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Xinwei Liu
- Listed since
- Dec 12, 2022
- Employees
- 893
Market position
Day range
Current HK$4.69
52-week range
Current HK$4.69
- Open
- HK$4.49
- Previous close
- HK$4.40
- Volume
- 32.3K
- 0.65× average
- Average volume
- 49.77K
- Average daily volume
- Market cap
- 693.59M HKD
- Beta
- 0
- Market reference 1
- 50-day average
- HK$4.9484
- -5.22% below average
- 200-day average
- HK$6.2699
- -25.20% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 1.14B CNY
- P/E (TTM)
- 6.09×
- P/B (TTM)
- 0.34×
- P/S (TTM)
- 0.43×
- EV / EBITDA
- 6.72×
- Earnings yield
- 8.96%
- Free cash flow yield
- 10.29%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 45.87%
- Operating margin
- 8.81%
- Net margin
- 6.97%
- Return on equity
- 5.70%
- Return on assets
- 3.66%
- Return on invested capital
- 4.16%
Financial health
- Debt / equity
- 0.3×
- Current ratio
- 2.4×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.38B CNY | 1.43B CNY | 1.41B CNY | 1.25B CNY | 1.3B CNY |
| Cost of goods sold | 747.16M CNY | 765.01M CNY | 714.64M CNY | 628.45M CNY | 688.75M CNY |
| Gross profit | 633.2M CNY | 663.39M CNY | 691.6M CNY | 625.34M CNY | 609.47M CNY |
| Research and development | 92.58M CNY | 78.42M CNY | 52.88M CNY | 41.09M CNY | 23.51M CNY |
| Selling, general, and administrative | 418.98M CNY | 378.36M CNY | 378.21M CNY | 333.94M CNY | 320.99M CNY |
| Operating expenses | 511.55M CNY | 437.37M CNY | 412.45M CNY | 360.53M CNY | 330.59M CNY |
| Interest income | 2.46M CNY | 3.18M CNY | 6.58M CNY | 4.68M CNY | 2.02M CNY |
| Interest expense | 19.59M CNY | 36.71M CNY | 50.61M CNY | 42.68M CNY | 83.53M CNY |
| Depreciation and amortization | 57.1M CNY | 52.76M CNY | 75.97M CNY | 44.87M CNY | 43.88M CNY |
| Operating income | 121.65M CNY | 197.19M CNY | 279.16M CNY | 246.22M CNY | 257.12M CNY |
| Net income | 96.19M CNY | 92.39M CNY | 173.52M CNY | −349.62M CNY | −190.45M CNY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 0.45
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
2407.HK peers
ETFs holding 2407.HK
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research 2407.HKresearch.disclaimer







